Company profilePharmaceutical#54 of 1,318 in Pakistan2 DRAP alerts

EFROZE CHEMICAL INDUSTRIES (PVT) LTD.

Pharmaceutical company · 234 brands · 192 molecules

Ranked #35 of 112 companies in Blood Glucose Lowering Drugs, Excluding Insulin

234 registered products 66 pharmaceutical brands 192 distinct molecules 2 DRAP alerts

Company overview

234
registered products
66
pharmaceutical brands
192
distinct molecules
12
therapeutic classes
2
DRAP alerts

EFROZE CHEMICAL INDUSTRIES (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 234 product registrations across 192 distinct molecules. It is the 54th largest registrant in Pakistan by product count, and ranks 35th of 112 in Blood Glucose Lowering Drugs, Excluding Insulin. Its portfolio is concentrated in Blood Glucose Lowering Drugs, Excluding Insulin and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). DRAP has issued 2 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by EFROZE

75 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

39
ceilings with an approval date
3
not revised in 2+ years
2024
oldest approval year
20243
202533
20263
Longest without revision

Top molecules by brand count

Therapeutic classes

Blood Glucose Lowering Drugs, Excluding Insulin · 5Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 3Cardiac Therapy · 3Antacid · 2Angiotensin-Ii Antagonists, Combinations · 2Other Analgesics And Antipyretics · 2Beta Blocking Agent · 1Hormone Regulators · 1Oestrogens · 1Anthelmintic · 1Pain Management · 1Gastro · 1

Conditions treated

Contraceptives · 1Pain Killers · 1Ulcer/Reflux/Flatulence/Acidity · 1Epilepsy/Convulsion · 1Angina · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official47 products · Rs 25.67 – Rs 23,611.2
DVAGO16 products · Rs 40 – Rs 346.8
Servaid5 products · Rs 50.36 – Rs 755
Median across source: Rs 305

Regulatory record

2 alerts in the DRAP feed we track.

Recall Alert: Drug Product; Piperazine Elixer (Batch # L-085) by Swat Pharmaceuticals, Swa
2023-11-24
Drug Safety Alert: Risk of Anaphylactic Reaction / Anaphylactic Shock with Diclofenac Sodi
2022-11-18

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 141 molecules not in this portfolio
AlbuterolAmikacinAminophyllineAmlodipineAmlodipine BaseAmmonium Chloride
Wilshire Laboratories (Private) Limited holds 118 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
Atco Pharma International (Pvt) Ltd holds 217 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline

Get the full profile for EFROZE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.